What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 — New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
Mar 8, 2024 — The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
Obesity drug Wegovy is approved to cut heart ... - Associated Press News
Mar 8, 2024 — The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight …
Wegovy Approved By FDA to Reduce Heart Attack Risk - The New York Times
Mar 11, 2024 — Wegovy, the blockbuster weight loss drug, is now approved for a new use: reducing the risk of heart attacks, strokes and cardiovascular-related death in adults who have heart disease and are...
Wegovy approved to lessen heart attack, stroke risk in overweight ...
Mar 8, 2024 — The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in...
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, …
Nov 11, 2023 — A pivotal new study suggests that the weight loss drug Wegovy cut the risk of heart attack, stroke or death from cardiovascular issues by 20 percent among overweight or obese people...
Obesity drug Wegovy cut risk of serious heart ... - Associated Press News
Nov 11, 2023 — A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients. The international trial showed the weekly injections prevented heart attacks, strokes and heart-related deaths.
Wegovy shown to reduce risk of heart attack, stroke in major ...
Aug 8, 2023 — The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular...
News details - Novo Nordisk
PLAINSBORO, N.J., March 8, 2024 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Wegovy ® to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along ...